BioNTech Se (BNTX) Q3 2024 Earnings Call Transcript
Welcome to BioNTech's third quarter 2024 earnings call. I would like to hand the call over to Michael Horowicz director, investor relations. Please go ahead. Michael Horowicz-- Vice President, Strategy and Investor Relations Thank you. Good morning and ...
BioNTech (BNTX) Scheduled to Post Quarterly Earnings on Monday
BioNTech (NASDAQ:BNTX – Get Free Report) will be announcing its earnings results before the market opens on Monday, November 4th. Analysts expect the company to announce earnings of ($1.06) per share for the quarter.
BioNTech SE (NASDAQ:BNTX) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 4, 2024 Operator: Welcome to BioNTech’s Third Quarter 2024 Earnings Call. I would like to hand the call over to Michael Horowicz, Director of Investor Relations.
Marqeta (MQ) Q3 2024 Earnings Call Transcript
At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator instructions] As a reminder, this conference is being recorded.
Brightcove Inc. (BCOV) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ETCompany ParticipantsMarc DeBevoise - Chief Executive
AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Nov 04, 2024, 5:00 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Partici
BioNTech price target lowered to $122 from $132 at TD Cowen
TD Cowen lowered the firm’s price target on BioNTech (BNTX) to $122 from $132 and keeps a Hold rating on the shares. The firm noted ...
MT Newswires on MSN22h
BioNTech Sees Full-Year Revenue at Low End of Guidance; Third-Quarter Results Rise
BioNTech (BNTX) said on Monday that it expects full-year revenue at the low end of its guidance due in part to inventory write-downs, even as variant-adapted COVID-19 vaccines helped the German ...
FiercePharma1d
BioNTech reports surprising COVID vaccine sales in Q3 but tempers expectations for annual sales
Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...
Deutsche Bank Sticks to Their Buy Rating for BioNTech SE (BNTX)
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...
BioNTech Third Quarter 2024 Earnings: Beats Expectations
Third Quarter 2024 Results Key Financial Results Revenue: €1.24b (up 39% from 3Q 2023).
2,051 Shares in BioNTech SE (NASDAQ:BNTX) Purchased by Mount Yale Investment Advisors LLC
Mount Yale Investment Advisors LLC acquired a new stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) in the third quarter, according to the company in its most recent 13F filing with the ...
Why is Pfizer stock falling after Q3 results?
Pfizer (PFE) stock fell even as the company beat forecasts with its Q3 results and increased its full-year outlook.Find out ...
BioNTech lowers full-year revenue outlook on COVID-19 seasonality, inventory write-downs
German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels, ...
BioNTech’s Q3 2024: Strong Revenue and Oncology Progress
BioNTech SE (BNTX) has released an update. BioNTech SE reported a strong third quarter in 2024, with revenues reaching €1.2 ...
Pfizer raises guidance as COVID franchise drives Q3 beat
Pfizer (PFE) stock gained after the company beat estimates with its Q3 2024 financials and raised its full-year guidance ...